Efficient priming of protein antigen-specific human CD4+ T cells by monocyte-derived dendritic cells

Blood

Volumn 96, Issue 10, 2000, Pages 3490-3498

  Schlienger, K ^a   Craighead, N ^a   Lee, K P ^a   Levine, B L ^a   June, C H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 12; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0034670014     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.10.3490     Document Type: Article

References (42)

1. Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells
2. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication
3. Nonphagocytic dendritic cells are effective accessory cells for anti-mycobacterial responses in vitro
4. The dendritic cell system and its role in immunogenicity
5. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells
6. Dendritic cells: Unique leukocyte populations which control the primary immune response
7. Dendritic cells and the control of immunity
8. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
9. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
10. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimutating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
11. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
12. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
13. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
14. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
15. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
16. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells
17. Generation of CD1+ RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes
18. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
19. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production
20. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells
21. Generation of antigen-specific CD4+ T cell lines from naive precursors
22. Dendritic cells that process and present nominal antigens to naive T lymphocytes are derived from CD2+ presursors
23. Expression of trimeric CD40 ligand in Pichia pastoris: Use of a rapid method to detect high-level expressing transformants
24. Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: Evidence for protein kinase C-mediated signaling
25. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
26. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression
27. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro
28. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro
29. Immunology: License to kill
30. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
31. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
32. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity
33. Developmental regulation of MHC class II transport in mouse dendritic cells
34. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
35. CD40-activated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunetherapy
36. The duration of antigenic stimulation determines the fate of naive and effector T cells
37. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help
38. Help for cytotoxic T-cell responses is mediated by CD40 signalling
39. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
40. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
41. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells
42. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation